RxDoctor Payments Data

Tracy Tarvers

Family · Forsyth, GANPI 1093315848

Payments from drug & device makers

$2,581in general payments, 2019–2025

Across 98 payments — averaging $26.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$851
  • Novo Nordisk$345
  • AstraZeneca$290
  • Pfizer$240
  • Neurocrine Biosciences, Inc.$204
  • Amgen$129
  • plus $522 from 17 others

What the payments were for

  • Food & beverage$2,581100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,581 in reported general payments places this provider in the 80th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide55$59,541
FarxigaDapagliflozin Propanediol77$55,750
EliquisApixaban51$39,962
JardianceEmpagliflozin36$32,372
MounjaroTirzepatide15$29,216
TrulicityDulaglutide21$25,575
RybelsusSemaglutide19$22,403
EntrestoSacubitril/Valsartan24$15,619
MyrbetriqMirabegron22$11,847
LinzessLinaclotide15$10,625
JanuviaSitagliptin Phosphate14$10,618
DapagliflozinDapagliflozin Propanediol14$6,584
Tresiba Flextouch U-100Insulin Degludec19$5,606
Gabapentin234$3,325
Memantine Hcl85$2,050

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$345$81,94474 claims
AstraZenecaFarxiga$290$55,75077 claims
Lilly USA, LLCMounjaro, Trulicity$69$54,79136 claims
PfizerEliquis$240$39,96251 claims
Boehringer IngelheimJardiance$45$32,37236 claims
AbbVieLinzess$851$10,62515 claims
MerckJanuvia$19$10,61814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,258 family providers in Georgia.

Other family in Forsyth

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →